Khagendra Dahal is a Cardiology physician affiliated with Creighton University. OpenAlex indexes 117 publications with 1,167 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
263 Farmington Ave
Farmington, CT 060321956
Telephone
860-679-2000Provider last certified this registry record 30 Jan 2026.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- W. L. Gore & Associates, Inc.Program year202525 payments
- Medtronic, Inc.Program year202539 payments
- Edwards Lifesciences CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Beta blocker27.8%Metoprolol Succinate61%Carvedilol24%Metoprolol Tartrate16%Part D≥59 patientsLoop diuretic16.7%Furosemide76%Bumetanide14%Torsemide10%Part D<11 patients+ 10 more classes in this area
Blood & clotting
10.5%Factor Xa inhibitor6.4%Eliquis100%Part D≥23 patientsP2Y12 inhibitor3%Clopidogrel100%Part D≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.6%Potassium supplement5.6%Potassium Chloride100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Efficacy of DOAC Versus VKA in Adult Congenital Heart Disease: A Systematic Review and Meta-Analysis
American Journal of Cardiovascular Drugs
2025 - SODIUM RESTRICTION IN HEART FAILURE: A META-ANALYSIS OF RANDOMIZED TRIALS
Journal of the American College of Cardiology
2023 - Drug-Eluting Stent Versus Bare Metal Stent for Femoropopliteal Peripheral Artery Disease: A Systematic Review and Meta-Analysis
Cardiovascular revascularization medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Beart, MD
Creighton University
Alan Thorson, MD
Creighton University
Aryan Mooss, MD
Creighton University
Ross Bremner, MD
Creighton University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”